Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: J ECT. 2017 Dec;33(4):268–271. doi: 10.1097/YCT.0000000000000413

Table 1.

Descriptive statistics

Total (n=16) Ketamine (n=8) Methohexital (n=8)
Age (years, mean±sd) 40.9±14.1 43.6±14.6 38.1±13.9
Gender (n (%))
 Male 3 (18.8) 2 (25.0) 1 (12.5)
 Female 13 (81.3) 6 (75.0) 7 (87.5)
Education (years, mean±sd) 13.1±2.7 13.0±2.1 13.1±3.3
SCID Diagnosis (%)
 Unipolar Depression 11 (68.8) 6 (75.0) 5 (62.5)
 Bipolar Depression 5 (31.3) 2 (25.0) 3 (37.5)
Baseline Measures (mean±sd)
 BDI 35.0±7.6 34.0±4.5 36.0±10.0
 HAM-D (17 Item) 26.6±4.0 27.4±5.0 25.8±2.7
 MMSE 26.8±2.2 27.5±2.1 26.0±2.1
ECT Parameters (mean±sd)
Number of Treatments 4.9±1.3 5.1±1.0 4.6±1.6
Electrical Dose 52.5±30.4 54.0±27.7 50.8±33.5
Motor Seizure Duration (seconds) 35.9±14.7 35.3±12.0 36.7±17.5
Central Seizure Duration (seconds) 65.7±41.2 55.5±22.2 77.8±54.0
Treatment Response (%)
Responders 6 (37.5) 4 (50.0) 2 (25.0)
Remitters 1 (6.3) 1 (12.5) 0 (0.0)
HHS Vulnerability Disclosure